OncohematologyOncohematologyОнкогематология1818-83462413-4023Publishing House ABV Press1022LITERATURE REVIEWОБЗОР ЛИТЕРАТУРЫИнвазивные микозы у реципиентов аллогенных гемопоэтических стволовых клеток: современное состояние проблемыhttps://orcid.org/0000-0001-9230-69603021-3170МироноваДарья Александровна
Russian Federation

врач-гематолог отделения химиотерапии гемобластозов и трансплантации костного мозга и гемопоэтических стволовых клеток ФГБУ "НМИЦ гематологии" МЗ РФ

mrnvdaria@gmail.comhttps://orcid.org/0000-0001-6201-62764889-9529КузьминаЛариса Анатольевна
Russian Federation

врач-гематолог, заведующая отделением химиотерапии гемобластозов и трансплантации костного мозга и гемопоэтических стволовых клеток, кандидат медицинских наук

kuzlara@rambler.ruhttps://orcid.org/0000-0001-5973-57634327-8048КлясоваГалина Александровна
Russian Federation

Профессор, доктор медицинских наук, заведующий отделом микробиологии и антимикробной терапии, врач-клинический фармаколог — руководитель группы клинической фармакологии антимикробных препаратов

 

Klyasova.g@blood.ruФГБУ "НМИЦ гематологии" МЗ РФ1109202520330042025Copyright ©; 2025, ABV-pressCopyright ©; 2025, АБВ-­пресс2025ABV-pressАБВ-­прессhttps://oncohematology.abvpress.ru/ongm/about/editorialPolicieshttps://oncohematology.abvpress.ru/ongm/article/view/1022

Трансплантация аллогенных стволовых клеток – непременная составляющая лечения ряда гематологических заболеваний. За последние годы отмечается рост трансплантационной активности по всему миру, увеличение доли альтернативных доноров. Следует отметить, что несмотря на противогрибковую профилактику, у реципиентов аллогенных гемопоэтических стволовых клеток сохраняется высокий риск развития инвазивного микоза. В данном обзоре представлено современное состояние проблемы по факторам риска, частоте и структуре инвазивных микозов у этой категории больных.

трансплантация аллогенных гемопоэтических стволовых клетокинвазивный микозпротивогрибковая профилактикаинвазивный аспергиллезнейтропенияреакция «трансплантат против хозяина»1. Passweg J.R. et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years // Bone Marrow Transplantation 2021 56:7. Nature Publishing Group, 2021. Vol. 56, № 7. P. 1651–1664.Passweg J.R. et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years // Bone Marrow Transplantation 2021 56:7. Nature Publishing Group, 2021. Vol. 56, № 7. P. 1651–1664.2. Менделеева Л.П. et al. Анализ трансплантационной активности в РФ за 2018 г. (отчет межрегионального регистра) // Гематология и трансфузиология. ОАО «Издательство «Медицина», 2020. Vol. 65, № S1.Менделеева Л.П. et al. Анализ трансплантационной активности в РФ за 2018 г. (отчет межрегионального регистра) // Гематология и трансфузиология. ОАО «Издательство «Медицина», 2020. Vol. 65, № S1.3. Vasilyeva V.A. et al. Выполнение трансплантаций аллогенных гемопоэтических стволовых клеток от неродственных доноров из Российского и зарубежного регистров в одном трансплантационном центре // Гематология и трансфузиология. Meditsina Publishers, 2020. Vol. 65, № 3. P. 299–311.Vasilyeva V.A. et al. Выполнение трансплантаций аллогенных гемопоэтических стволовых клеток от неродственных доноров из Российского и зарубежного регистров в одном трансплантационном центре // Гематология и трансфузиология. Meditsina Publishers, 2020. Vol. 65, № 3. P. 299–311.4. Rubinstein S.M. et al. Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies // Bone Marrow Transplantation 2018 53:2. Nature Publishing Group, 2017. Vol. 53, № 2. P. 123–128.Rubinstein S.M. et al. Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies // Bone Marrow Transplantation 2018 53:2. Nature Publishing Group, 2017. Vol. 53, № 2. P. 123–128.5. Tomblyn M. et al. Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective EXECUTIVE COMMITTEE Background to HCT // Biol Blood Marrow Transplant. 2009. Vol. 15. P. 1143–1238.Tomblyn M. et al. Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective EXECUTIVE COMMITTEE Background to HCT // Biol Blood Marrow Transplant. 2009. Vol. 15. P. 1143–1238.6. Neofytos D. et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: Analysis of multicenter prospective antifungal therapy (PATH) alliance registry // Clinical Infectious Diseases. Oxford Academic, 2009. Vol. 48, № 3. P. 265–273.Neofytos D. et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: Analysis of multicenter prospective antifungal therapy (PATH) alliance registry // Clinical Infectious Diseases. Oxford Academic, 2009. Vol. 48, № 3. P. 265–273.7. Kontoyiennis D.P. et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the transplant- associated infection surveillance network (TRANSNET) database // Clinical Infectious Diseases. Oxford Academic, 2010. Vol. 50, № 8. P. 1091–1100.Kontoyiennis D.P. et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the transplant- associated infection surveillance network (TRANSNET) database // Clinical Infectious Diseases. Oxford Academic, 2010. Vol. 50, № 8. P. 1091–1100.8. Girmenia C. et al. Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) // Biology of Blood and Marrow Transplantation. Elsevier, 2014. Vol. 20, № 6. P. 872–880.Girmenia C. et al. Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) // Biology of Blood and Marrow Transplantation. Elsevier, 2014. Vol. 20, № 6. P. 872–880.9. Martino R. et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients // British journal of haematology. Br J Haematol, 2002. Vol. 116, № 2. P. 475–482.Martino R. et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients // British journal of haematology. Br J Haematol, 2002. Vol. 116, № 2. P. 475–482.10. Pagano L. et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne // Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Clin Infect Dis, 2007. Vol. 45, № 9. P. 1161–1170.Pagano L. et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne // Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Clin Infect Dis, 2007. Vol. 45, № 9. P. 1161–1170.11. Nucci M. et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil // Clinical Microbiology and Infection. Elsevier, 2013. Vol. 19, № 8. P. 745–751.Nucci M. et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil // Clinical Microbiology and Infection. Elsevier, 2013. Vol. 19, № 8. P. 745–751.12. Kuster S. et al. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study // Transplant Infectious Disease. Blackwell Publishing Inc., 2018. Vol. 20, № 6.Kuster S. et al. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study // Transplant Infectious Disease. Blackwell Publishing Inc., 2018. Vol. 20, № 6.13. Souza L. et al. Epidemiology of invasive fungal disease in haematologic patients // Mycoses. John Wiley & Sons, Ltd, 2021. Vol. 64, № 3. P. 252–256.Souza L. et al. Epidemiology of invasive fungal disease in haematologic patients // Mycoses. John Wiley & Sons, Ltd, 2021. Vol. 64, № 3. P. 252–256.14. Gao L. et al. Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: A multicenter prospective observational study // Journal of Hematology and Oncology. BioMed Central Ltd., 2016. Vol. 9, № 1. P. 1–12.Gao L. et al. Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: A multicenter prospective observational study // Journal of Hematology and Oncology. BioMed Central Ltd., 2016. Vol. 9, № 1. P. 1–12.15. Клясова Г.А. Инвазивные микозы у больных острыми лейкозами и у реципиентов гемопоэтических стволовых клеток. Результаты многоцентрового проспективного наблюдательного исследования в России (RIFI) // Гематология и трансфузиология. 2016.Клясова Г.А. Инвазивные микозы у больных острыми лейкозами и у реципиентов гемопоэтических стволовых клеток. Результаты многоцентрового проспективного наблюдательного исследования в России (RIFI) // Гематология и трансфузиология. 2016.16. Cesaro S. et al. Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Tran // Clinical Infectious Diseases. Oxford Academic, 2018. Vol. 67, № 4. P. 564–572.Cesaro S. et al. Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Tran // Clinical Infectious Diseases. Oxford Academic, 2018. Vol. 67, № 4. P. 564–572.17. Robin C. et al. Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire // Biology of Blood and Marrow Transplantation. Elsevier, 2019. Vol. 25, № 2. P. 354–361.Robin C. et al. Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire // Biology of Blood and Marrow Transplantation. Elsevier, 2019. Vol. 25, № 2. P. 354–361.18. Martino R. et al. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the Euro // Blood. The American Society of Hematology, 2006. Vol. 108, № 9. P. 2928.Martino R. et al. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the Euro // Blood. The American Society of Hematology, 2006. Vol. 108, № 9. P. 2928.19. Popova M.O. et al. Invasive fungal infections in recipients of allogeneic hematopoietic stem cell teens and young adults // Russian Journal of Children Hematology and Oncology. 2016. Vol. 3, № 1. P. 44–51.Popova M.O. et al. Invasive fungal infections in recipients of allogeneic hematopoietic stem cell teens and young adults // Russian Journal of Children Hematology and Oncology. 2016. Vol. 3, № 1. P. 44–51.20. Busca A. et al. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience // Frontiers in Cellular and Infection Microbiology. Frontiers Media S.A., 2022. Vol. 11. P. 1354.Busca A. et al. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience // Frontiers in Cellular and Infection Microbiology. Frontiers Media S.A., 2022. Vol. 11. P. 1354.21. Papanicolaou G.A. et al. Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis // Transplantation and cellular therapy. Transplant Cell Ther, 2023.Papanicolaou G.A. et al. Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis // Transplantation and cellular therapy. Transplant Cell Ther, 2023.22. Penack O. et al. Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party // eClinicalMedicine. Elsevier, 2024. Vol. 67. P. 102393.Penack O. et al. Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party // eClinicalMedicine. Elsevier, 2024. Vol. 67. P. 102393.23. Cornely O.A. et al. Defining Breakthrough Invasive Fungal Infection– Position Paper of the Mycoses Study Group Education and Research Consortium (MSG-ERC) and the European Confederation of Medical Mycology (ECMM) // Mycoses. NIH Public Access, 2019. Vol. 62, № 9. P. 716.Cornely O.A. et al. Defining Breakthrough Invasive Fungal Infection– Position Paper of the Mycoses Study Group Education and Research Consortium (MSG-ERC) and the European Confederation of Medical Mycology (ECMM) // Mycoses. NIH Public Access, 2019. Vol. 62, № 9. P. 716.24. Van Burik J.A.H. et al. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients // Medicine. Medicine (Baltimore), 1998. Vol. 77, № 4. P. 246–254.Van Burik J.A.H. et al. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients // Medicine. Medicine (Baltimore), 1998. Vol. 77, № 4. P. 246–254.25. Lamoth F. et al. Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis // Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Clin Infect Dis, 2017. Vol. 64, № 11. P. 1619–1621.Lamoth F. et al. Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis // Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Clin Infect Dis, 2017. Vol. 64, № 11. P. 1619–1621.26. Trifilio S. et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole // Bone Marrow Transplantation. 2007. Vol. 40, № 5. P. 451–456.Trifilio S. et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole // Bone Marrow Transplantation. 2007. Vol. 40, № 5. P. 451–456.27. Bergamasco M.D. et al. Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach // Journal of Fungi. Multidisciplinary Digital Publishing Institute (MDPI), 2021. Vol. 7, № 8.Bergamasco M.D. et al. Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach // Journal of Fungi. Multidisciplinary Digital Publishing Institute (MDPI), 2021. Vol. 7, № 8.28. Roth R.S. et al. Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress? // Open forum infectious diseases. Open Forum Infect Dis, 2021. Vol. 9, № 1.Roth R.S. et al. Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress? // Open forum infectious diseases. Open Forum Infect Dis, 2021. Vol. 9, № 1.29. Sun Y. et al. Epidemiology, Management, and Outcome of Invasive Fungal Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation in China: A Multicenter Prospective Observational Study // Biology of Blood and Marrow Transplantation. Elsevier, 2015. Vol. 21, № 6. P. 1117–1126.Sun Y. et al. Epidemiology, Management, and Outcome of Invasive Fungal Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation in China: A Multicenter Prospective Observational Study // Biology of Blood and Marrow Transplantation. Elsevier, 2015. Vol. 21, № 6. P. 1117–1126.30. Posteraro B. et al. Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis // Mycoses. John Wiley & Sons, Ltd, 2020. Vol. 63, № 9. P. 900–910.Posteraro B. et al. Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis // Mycoses. John Wiley & Sons, Ltd, 2020. Vol. 63, № 9. P. 900–910.